Medicare's uncapped drug costs take a big bite from already tight budgets

Three times a week, 66-year-old Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After living with the disease for more than 20 years, the self-employed certified financial planner in Mashpee, Mass., is accustomed to managing his condition. What he can't get used to is how Medicare's coinsurance charges put a strain on his wallet.